Shares of Immucor, Inc. BLUD are shooting higher mid-day and are currently up by 4.74%, trading at $17.68.
Options traders are buying calls on the name today. A short while ago the December $20.00 call was purchased 1,500 times, on the offer, on open interest of only 211 contracts. This was followed by small lot call buying on the November $17.50 and $20.00 strikes
Overall call volume is now running at over 13x the daily average, with 90% of all calls traded being purchases on the offer.
Immucor, Inc. develops, manufactures and sells a line of reagents and automated systems that detect and identify certain properties of the cell and serum components of human blood for the purpose of blood transfusion. Its offerings are targeted at hospitals, donor centers and reference laboratories.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in